Psychotherapy Solutions, Llc - Medicare Mental Health Clinic in Avon, CT

Psychotherapy Solutions, Llc is a medicare enrolled mental health clinic (Social Worker - Clinical) in Avon, Connecticut. The current practice location for Psychotherapy Solutions, Llc is 40 Tower Ln, Avon, Connecticut. For appointments, you can reach them via phone at (860) 677-1800. The mailing address for Psychotherapy Solutions, Llc is 40 Tower Ln, Avon, Connecticut and phone number is (860) 677-1800.

Psychotherapy Solutions, Llc is licensed to practice in Connecticut (license number 008900). The clinic also participates in the medicare program and its NPI number is 1245613231. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (860) 677-1800.

Contact Information

Psychotherapy Solutions, Llc
40 Tower Ln
Avon
CT 06001-4222
(860) 677-1800
Not Available

Mental Health Clinic Profile

Full NamePsychotherapy Solutions, Llc
SpecialitySocial Worker
Location40 Tower Ln, Avon, Connecticut
Authorized Official Name and PositionPamela H Lefever (MEMBER)
Authorized Official Contact8606771800
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Psychotherapy Solutions, Llc
40 Tower Ln
Avon
CT 06001-4222

Ph: (860) 677-1800
Psychotherapy Solutions, Llc
40 Tower Ln
Avon
CT 06001-4222

Ph: (860) 677-1800

NPI Details:

NPI Number1245613231
Provider Enumeration Date07/08/2015
Last Update Date07/08/2015

Medicare PECOS Information:

Medicare PECOS PAC ID4981912953
Medicare Enrollment IDO20150925000124

News Archive

Ganeden Biotech and NFO announce new partnership agreement

Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC30®, today announced a new partnership agreement with the National Farmers Organization (NFO), a group marketing and price negotiation organization for the nation's farmers, ranchers and dairymen.

Blood test could enable early detection of cancer in people with neurofibromatosis type 1

People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't been a good way to determine whether this transformation to cancer has happened.

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.

Scientists develop new synthetic material to grow stem cells

Human pluripotent stem cells, which can become any other kind of body cell, hold great potential to treat a wide range of ailments, including Parkinson's disease, multiple sclerosis and spinal cord injuries. However, scientists who work with such cells have had trouble growing large enough quantities to perform experiments - in particular, to be used in human studies. Furthermore, most materials now used to grow human stem cells include cells or proteins that come from mice embryos, which help stimulate stem-cell growth but would likely cause an immune reaction if injected into a human patient.

Industry continues to give thumbs up to overhaul

On Tuesday, "[p]rovider groups hailed the president's historic signing of the Senate's healthcare reform bill, which seeks to overhaul the healthcare system through the establishment of a new insurance marketplace, expansions to Medicaid and various insurance reforms," Modern Healthcare reports.

Read more Medical News

› Verified 3 days ago

Medical Identifiers

Medical identifiers for Psychotherapy Solutions, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1245613231NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical 008900 (Connecticut)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Psychotherapy Solutions, Llc acts as a billing entity for following providers:
Provider NamePamela Lefever
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1154673796
PECOS PAC ID: 5890003867
Enrollment ID: I20150925000298

News Archive

Ganeden Biotech and NFO announce new partnership agreement

Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC30®, today announced a new partnership agreement with the National Farmers Organization (NFO), a group marketing and price negotiation organization for the nation's farmers, ranchers and dairymen.

Blood test could enable early detection of cancer in people with neurofibromatosis type 1

People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't been a good way to determine whether this transformation to cancer has happened.

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.

Scientists develop new synthetic material to grow stem cells

Human pluripotent stem cells, which can become any other kind of body cell, hold great potential to treat a wide range of ailments, including Parkinson's disease, multiple sclerosis and spinal cord injuries. However, scientists who work with such cells have had trouble growing large enough quantities to perform experiments - in particular, to be used in human studies. Furthermore, most materials now used to grow human stem cells include cells or proteins that come from mice embryos, which help stimulate stem-cell growth but would likely cause an immune reaction if injected into a human patient.

Industry continues to give thumbs up to overhaul

On Tuesday, "[p]rovider groups hailed the president's historic signing of the Senate's healthcare reform bill, which seeks to overhaul the healthcare system through the establishment of a new insurance marketplace, expansions to Medicaid and various insurance reforms," Modern Healthcare reports.

Read more Medical News

› Verified 3 days ago

News Archive

Ganeden Biotech and NFO announce new partnership agreement

Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC30®, today announced a new partnership agreement with the National Farmers Organization (NFO), a group marketing and price negotiation organization for the nation's farmers, ranchers and dairymen.

Blood test could enable early detection of cancer in people with neurofibromatosis type 1

People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't been a good way to determine whether this transformation to cancer has happened.

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.

Scientists develop new synthetic material to grow stem cells

Human pluripotent stem cells, which can become any other kind of body cell, hold great potential to treat a wide range of ailments, including Parkinson's disease, multiple sclerosis and spinal cord injuries. However, scientists who work with such cells have had trouble growing large enough quantities to perform experiments - in particular, to be used in human studies. Furthermore, most materials now used to grow human stem cells include cells or proteins that come from mice embryos, which help stimulate stem-cell growth but would likely cause an immune reaction if injected into a human patient.

Industry continues to give thumbs up to overhaul

On Tuesday, "[p]rovider groups hailed the president's historic signing of the Senate's healthcare reform bill, which seeks to overhaul the healthcare system through the establishment of a new insurance marketplace, expansions to Medicaid and various insurance reforms," Modern Healthcare reports.

Read more News

› Verified 3 days ago

Social Worker in Avon, CT

Counseling Ap
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 40 Avon Meadow Ln Bldg 40, Avon, CT 06001
Phone: 860-944-1700    
Helena E Gagnon
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 304 W Main St, Avon, CT 06001
Phone: 413-486-0981    Fax: 413-707-1032
Liberty Treatment Of Virginia
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 55 Great Meadow Ln, Avon, CT 06001
Phone: 959-226-8411    
U Are Heard Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 302 W Main St Ste 201, Avon, CT 06001
Phone: 860-836-3821    
Jennifer M. Lapenta, Lcsw, L.l.c.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 60 Avon Meadow Ln, Suite 6, Avon, CT 06001
Phone: 860-761-3896    
Rahel K. Saroff Counseling Services Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7 Towpath Lane, Avon, CT 06001
Phone: 860-335-6707    
Hartford Healthcare Urgent Care Centers, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 385 W Main St, Avon, CT 06001
Phone: 860-696-2150    Fax: 860-696-2160

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.